NCT07030426View on ClinicalTrials.gov

Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2029

Conditions
Pelvic Organ Prolapse (POP)
Interventions
DRUG

Vaginal Estrogen - Twice Weekly

Twice weekly for six weeks following pelvic organ prolapse repair surgery. 0.5 grams of cream per vagina at bedtime .

DRUG

Vaginal Estrogen - Daily

Daily for six weeks following pelvic organ prolapse repair surgery. 0.5 grams of cream per vagina at bedtime.

Trial Locations (2)

A1B 3X5

Health Sciences Centre, St. John's

K7L2V7

Kingston Health Sciences Centre, Kingston

All Listed Sponsors
lead

Queen's University

OTHER